
Hemorrhagic morbidity in placenta accreta spectrum with and without placenta previa
Author(s) -
Bethany M. Mulla,
Robert Weatherford,
Allyson M. Redhunt,
Anna M. Modest,
Michele R. Hacker,
Jonathan L. Hecht,
Melissa Spiel,
Scott A. Shainker
Publication year - 2019
Publication title -
archives of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.793
H-Index - 68
eISSN - 1432-0711
pISSN - 0932-0067
DOI - 10.1007/s00404-019-05338-y
Subject(s) - placenta previa , medicine , placenta accreta , obstetrics , placenta diseases , placenta , placenta percreta , hysterectomy , gynecology , retrospective cohort study , exact test , pregnancy , fetus , surgery , genetics , biology
The incidence of placenta accreta spectrum (PAS; pathologic diagnosis of placenta accreta, increta or percreta) continues to rise in the USA. The purpose of this study is to compare the hemorrhagic morbidity associated with PAS with and without a placenta previa.